Navigation Links
ShangPharma's Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
Date:8/11/2011

SHANGHAI, Aug. 11, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it has achieved the initial milestones for two multi-staged projects in its biologics division, which portends strong growth for this segment in 2011.

The initial milestones were achieved for two oncology projects that are under development for a major U.S.-based pharmaceutical company. ShangPharma launched the projects at the beginning of this year and reached these milestones earlier than anticipated. As a result, the Company is advancing into the second phase of development ahead of schedule. ShangPharma is also conducting another multi-stage project in immunology for the same client, and expects to reach the initial milestone in the near-term.

Over the past year, ShangPharma has greatly enhanced its technological platforms in biologics research, allowing for faster delivery of high quality R&D work. Currently, it possesses a complete platform for the preclinical development of therapeutic antibodies that can support early-stage target validation through the delivery of potential drug candidates. These broadened service offerings have resulted in a significant increase in its biologics division's pipeline for additional projects that are expected to start in the near-term. The Company is gaining wider acceptance due to its ability to perform integrated programs and it expects to enter into additional contracts with new customers including a top 20 global pharmaceutical company, a U.S.-based biotechnology company and a large domestic Chinese pharmaceutical company, during the second half of 2011. The Company also plans to have close to 100 employees in the biologics division by the end of 2011.  

Michael Xin Hui, foun
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
2. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
3. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
4. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
5. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
6. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
7. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
8. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
9. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
10. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
11. CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015 Sysmex America, ... equipment and information systems technology, today announces a ... company. This partnership allows Sysmex and its distributor ... solution for physician offices and clinics that connect ... Electronic Medical Record (EMR) systems. Physician ...
(Date:5/5/2015)... 2015  IBM Watson Health (NYSE: IBM ) ... a dozen leading cancer institutes to accelerate the ability ... their patients. The institutes will apply Watson,s ... to minutes the ability to translate DNA insights, understand ... medical literature to personalize treatment options. The project is ...
(Date:5/5/2015)... (Family Features) Which health screenings and exams ... adults, monitoring your weight, cholesterol, and blood pressure is ... about vision care? Photo - ... 40s, they often start to notice small changes in ... job performance. Whether having difficulty reading a book or ...
Breaking Medicine Technology:Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4
... UBM Conferences , a division of UBM Plc ... Extractables and Leachables Webinar to be hosted on May ... to attend webinar will evaluate the considerations to be ... development, in addition to highlighting how monomers and additives, ...
... ARBOR, Mich., May 16, 2012  Rubicon Genomics, Inc., ... sample-specific pre-analytical processes to improve the performance and ... research and clinical testing, today announced the launch ... family of sample preparation kits designed and optimized ...
Cached Medicine Technology:Global Webinar Focuses on Considerations for Extractables and Leachables 2Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications 2Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications 3
(Date:5/6/2015)... In celebration of their twentieth anniversary, ... they will give away a deluxe human hair lace wig ... steps to enter on a third-party giveaway tool. The important ... can be the winner. , The hair is a crown, ... destination for such a jewel for the past 20 years. ...
(Date:5/6/2015)... 06, 2015 Qualidigm , ... has hired healthcare executive Ann Olson, RN, BSN, ... will lead Qualidigm’s growing home healthcare services and ... improve the quality, safety, and cost-effectiveness of healthcare ... from Interim HealthCare of North Haven, Inc., a ...
(Date:5/6/2015)... Pass, OR (PRWEB) May 06, 2015 ... for maintaining eye health as we age, is fully ... the Sharon Kleyne Hour™ Power of Water® radio show. ... the need to drink sufficient water each day. As ... Nature’s Tears® EyeMist® for dry eye, Kleyne has extensive ...
(Date:5/6/2015)... 2015 Chinese technology company, Elink-IOT, has ... to raise AUD$150,000 to finalize development of Watcher, the ... smart watch designed to help the owner keep track ... when the item is out of range. , ... the wearer and sends alerts on its E-paper display, ...
(Date:5/6/2015)... LINET Americas has been awarded the ... small business category. The award was given for outstanding ... is given on an annual basis to foreign owned ... to philanthropy. Since 1998, the Charlotte International Cabinet ... Mayor’s International Community Awards. The award was presented to ...
Breaking Medicine News(10 mins):Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 2Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 3Health News:Crowdfunding campaign Launched for World’s First Anti-Loss Smart Watch 2Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2
... Dec. 10 N3 Oceanic, Inc. announced the addition of ... developed by cardiologist Dr. Jeffrey Shapiro, MD, Assistant Professor of ... and NYU Langone Medical Center, who has been giving the ... life-changing results. Dr. Shapiro states, Orosine is the most significant ...
... Global Med Technologies(R), Inc.,("Global Med" or the "Company") ... technology company, today announced that due to,inquiries from ... that was,received from Victory Park Capital Advisors, LLC ... Global Med,s Board of Directors to investigate various,business ...
... Botanical Council (ABC) has officially launched its Adopt-an-Herb program, ... ( Camellia sinensis ). For the next three years, ... ensure that abstracts (summaries) of the latest published scientific ... ABC,s HerbMedPro database, one of the most robust and ...
... Dec. 10 Genomma Lab Internacional,S.A.B. de C.V. (BMV: ... ("OTC") pharmaceuticals and personal care products company,announced today its ... growth without considering acquisitions in the range of 21% ... the range of 27% - 28%. These estimates,are ...
... stress of the economy,have you pulling your hair out? ... Now is the time to take a breather, rejuvenate, ... emotionally,physically and financially, which is why many spas are offering ... get the other half off,there is something for everyone. ...
... Dec. 10 Napo Pharmaceuticals, Inc. ("Napo"),is pleased ... for the license of crofelemer for all indications ... Japan, and certain,indications worldwide. Crofelemer is Napo,s ... 3 trial for the treatment of,chronic diarrhea in ...
Cached Medicine News:Health News:Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the 'Ultimate Cardio Protection' Against Heart Attacks, Strokes and Heart Failure. 2Health News:Global Med Technologies(R), Inc. Clarifies Proposal Received from Victory Park Capital Advisors, LLC 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 3Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 4Health News:Genomma Lab Announces 2009 Earnings Guidance 2Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 2Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 3Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 4Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 5
The Midas II Stainer is an automated slide stainer designed for use in hematology and microbiology laboratories....
... an "assembly-line worker" for routine staining protocols ... Programmable continuous slide stainer for routine stains. ... in short time. Its large number of ... working principle provides a high throughput. A ...
Cholesterol, Total. An automated analyzer test kits....
Intended for the quantitative determination of total cholesterol in serum. Reaction: Endpoint. Reaction complete within five minutes. Wavelength: 500 nm. Linearity: 700 mg/dL (18.1 mmol/L). Single st...
Medicine Products: